Gorączka Q

• Autorzy: Truszczynski M.

Warianty tytułu

EN

Q fever

• Języki publikacji: PL

Abstrakty

EN

The importance of Q fever from the veterinary and medical point of view was characterized, and the fact that the World Organisation for Animal Health (OIE) had classified it as a listed disease was mentioned. The reason for this classification was the zoonotic potential of Coxiella (C.) burnetii and its ubiquitous, global occurrence. The main properties of this microorganism were described. The epizootic of the Q fever outbreak in late 2009 in the Netherlands and control methods applied in goat and sheep farms were shortly described. The main reservoirs of the infection and transmission of C. burnetii to human beings were mentioned. A summary report on trends and sources of zoonoses and zoonotic agents in the European Union member countries in 2008 was cited in relation to Q fever monitoring in animals and in humans. The role of wildlife and domestic animals, particularly ruminants, as the reservoir of Q fever and the role of ticks in transmitting the infection to human beings and domestic animals were evaluated. Cows, sheep and goats, in particular their feces, urine, amniotic fluid and aborted fetuses, were indicated as the most important sources of infection. The aerogenic transmission of C. burnetii by aerosols from these sources was evaluated as the most frequent one. Other sources of infection of animals and humans were also mentioned. The symptoms of Q fever in humans and animals were described. The importance of Q fever to public health was underlined, noting that C. burnetii is highly pathogenic for human beings. In connection with this statement the role of veterinary prophylaxis of this zoonosis was emphasized. Diagnostic laboratory tests were mentioned as well as the general and specific prophylaxis of Q fever and the use of antibiotics in domestic ruminants. The authors made efforts to present important recent achievements in the research on Q fever and its etiological agent.

Słowa kluczowe

PL

choroby zwierzat; choroby odzwierzece; goraczka Q; etiologia; Coxiella burnetii; epidemiologia; objawy chorobowe; diagnostyka laboratoryjna; profilaktyka; szczepienia ochronne

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2011
• Tom: 67
• Numer: 01
• Opis fizyczny: s.15-19,bibliogr.

Twórcy

autor

Truszczynski M.

• Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy, Al. Partyzantów 57, 24-100 Puławy

Bibliografia

• 1.Angelakis E., Raoult D.: Q fever. Veterinary Microbiology 2010, 140, 297-309.
• 2.Anon.: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (mammals, birds and bees). World Organisation for Animal Health OIE 2008, 1, 4-9.
• 3.Anon.: OIE Terrestrial Animal Health Code. 2008, 1, 4-9.
• 4.Anon.: Q-Fieber in den Niederlanden. Tierärztliche Umschau 2010, 65, 90.
• 5.Anusz Z. (red.): Gor¹czka Q u ludzi i zwierz¹t. Wyd. ART, Olsztyn 1995, 1-219.
• 6.Anusz Z., Knap J.: Gor¹czka Q jako choroba ludzi i zwierz¹t. Pol. Tyg. Lekarski 1988, 49, 1603-1607.
• 7.Arricau-Bouvery N., Rodolakis A.: Is Q fever an emerging or reemerging zoonosis? Vet. Res. 2005, 36, 327-349.
• 8.Babudieri B.: Q fever. A zoonosis. Adv. Vet. Sci. 1959, 5, 82-182.
• 9.Berri M., Rousset E., Champion J. L., Russo P., Rodolakis A.: Goats may experience reproductive failures and shed Coxiella burnetii at two successive parturitions after a Q fever infection. Res. Vet. Sci. 2007, 83, 47-52.
• 10.Bouvery N. A., Souriau A., Lechopier P., Rodolakis A.: Experimental Coxiella burnetii infection in pregnant goats: excretion routes. Vet. Res. 2003, 34, 423-433.
• 11.Burnet F. M., Freeman M.: Experimental studies on the virus of "Q" fever. Med. J. Aust. 1937, 2, 299-305.
• 12.Capo C., Lindberg F. P., Meconi S., Zaffran Y., Tardei G., Brown E. J., Raoult D., Mege J. L.: Subversion of monocyte functions by Coxiella burnetii impairment of the cross-talk between avb3 integrin and CR3. J. Immunol. 1999, 163, 6078-6085.
• 13.Capo C., Moynault A., Collette Y., Olive D., Brown E. J., Raoult D., Mege J. L.: Coxiella burnetii avoids macrophage phagocytosis by interfering with spatial distribution of complement receptor 3. J. Immunol. 2003, 170, 4217-4225.
• 14.Chiu C. K., Durrheim D. N.: A review of the efficacy of human Q fever vaccine registered in Australia. N.S.W. Public Health Bull. 2007, 18, 133-136.
• 15.Gerth H. J., Leidig U., Riemenschneider T.: Q-fever Epidemie in einem Institut für Humanpathologie. Dt. Med. Wschr. 1982, 107, 1391-1395.
• 16.Hatchette T, Hudson R., Schlech W., Campbell N., Natchette J., Ratnam S., Donovan C., Marrie T.: Caprine-associated Q fever in Newfoundland. Can. Commun. Dis. Rep. 2000, 26, 17-19.
• 17.Hellenbrand W., Breuer T., Petersen L.: Changing epidemiology of Q fever in Germany, 1947-1999. Emerg. Infect. Dis. 2001, 7, 789-796.
• 18.Honstettre A., Ghigo E., Moynault A., Capo C., Toman R., Akira S., Takeuchi O., Lepidi H., Raoult D., Mege J. L.: Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4. J. Immunol. 2004, 172, 3695-3703.
• 19.Hotta A., Kawamura M., To H., Andoh M., Yamaguchi T., Fukushi H., Hirai K.: Phase variation analysis of Coxiella burnetii during serial passage in cell culture by use of monoclonal antibodies. Infect. Immun. 2002, 70, 4747-4749.
• 20.Huebner R. J., Bell J. A.: Q fever studies in Southern California. Summary of current results and a discussion of possible control measures. J. Am. Med. Assoc. 1951, 145, 301-305.
• 21.Johnson III J. E., Kadull P. J.: Laboratory acquired Q fever. A report of fifty cases. Am. J. Med. 1966, 41, 391-403.
• 22.Kelly P. J., Matthewaman L. A., Mason P. R., Raoult D.: Q fever in Zimbabwe. S. Afr. Med. J. 1993, 83, 21-25.
• 23.Khalili M., Sakhaee E.: An update on a serologic survey of Q Fever in domestic animals in Iran. Am. J. Trop. Med. Hyg. 2009, 80, 1031-1032.
• 24.Kovacova E., Kazar J.: Q fever-still a query and underestimated infectious disease. Acta Virol. 2002, 46, 193-210.
• 25.Kruszewska D., Tylewska-Wierzbanowska S. T.: Coxiella burnetii penetration into the reproductive system of male mice, promoting sexual transmission of infection. Infect. Immun. 1993, 61, 4188-4195.
• 26.Kruszewska D., Tylewska-Wierzbanowska S. T.: Isolation of Coxiella burnetii from bull semen. Res. Vet. Sci. 1997, 62, 299-300.
• 27.Kurzeja K.: Epidemiologia i klinika gor¹czki Q. PWRiL, Warszawa 1973.
• 28.Lang G. H.: Serosurvey of Coxiella burnetii infection in dairy goat herds in Ontario. Can. J. Vet. Res. 1988, 52, 37-41.
• 29.Mantovani A., Benazzi P.: The isolation of Coxiella burnetii from Rhipicephalus sanguineus on naturally infected dogs. J. Am. Vet. Med. Assoc. 1953, 122, 117-118.
• 30.Marrie T. J.: Epidemiology of Q fever, [w:] Raoult D., Parola P.: Rickettsial Diseases. Informa Healthcare, Inc. USA 2007, 281-289.
• 31.Marrie T. J., Langille D., Papukna V., Yates L.: Truckin pneumonia - an outbreak of Q fever in a truck repair plant probably due to aerosols from clothingh contaminated by contact with newborn kittens. Epidemiol. Infect. 1989, 102, 119-127.
• 32.Marrie T. J., Stein A., Janigan D., Raoult D.: Route of infection determines the clinical manifestations of acute Q fever. J. Infect. Dis. 1996, 173, 484-487.
• 33.Maurin M., Raoult D.: In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetii to clarithromycin. Antimicrob. Agents Chemothr. 1993, 37, 2633-2637.
• 34.Maurin M., Raoult D.: Q fever. Clin. Microbiol. Rev. 1999, 12, 518-553.
• 35.McQuisston J. H., Childs J. E.: Q fever in humans and animals in the United States. Vector Borne Zoonotic Dis. 2002, 2, 179-191.
• 36.Niemczuk K.: Gorączka Q jako zoonoza. Monografia. PIWet-PIB, Puławy 2006, 1-63.
• 37.Philip C. B.: Comments on the name of the Q fever organism. Public Health Rep. 1948, 63, 58-59.
• 38.Psaroulaki A., Hadjichristodoulou C., Loukaides F., Soteriades E., Konstantinidis A., Papastergious P., Ioannidou M. C., Tselentis Y.: Epidemiological study of Q fever in humans, ruminant animals, and ticks in Cyprus using a geographical information system. Eur. J. Clin. Microbiol. Infect. Dis. 2006, 25, 576-586.
• 39.Raoult D., Marrie T., Mege J.: Natural history and pathophysiology of Q fever. Lancet Infect. Dis. 2005, 5, 219-226.
• 40.Sanford E. S., Josephson G. K. A., MacDonald A.: Coxiella burnetii (Q fever) abortion storms in goat herds after attendance at an annual fair. Can. Vet. J. 1994, 35, 376-378.
• 41.Stoker M. G., Marmion B. P.: The spread of Q fever from animals to man. The natural history of a rickettsial disease. Bull. World Health Organ. 1955, 13, 781-806.
• 42.Thiele D., Karo M., Krauss H.: Monoclonal antibody based capture ELISA/ELIFA for detection of Coxiella burnetii in clinical specimens. Eur. J. Epidemiol. 1992, 8, 568-574.
• 43.Truszczyński M.: Gorączka Q - podstawowe dane o znaczeniu praktycznym. Życie Wet. 1983, 58, 148-150.
• 44.Truszczyński M.: Weterynaryjna profilaktyka zoonoz. Medycyna Wet. 2008, 64, 1363-1367.
• 45.Truszczyński M., Wijaszka T.: Zastąpienie listy A i B jedną listą chorób zgłaszanych do OIE. Medycyna Wet. 2005, 61, 234-235.
• 46.Webster J. P., LLoyd G., MacDonald D. W.: Q fever (Coxiella burnetii) reservoir in wild brown rat (Rattus norvegicus) populations in the UK. Parasitology 1995, 110, 31-35.
• 47.Wijaszka T., Truszczyński M.: Nowa lista chorób zgłaszanych do OIE. Medycyna Wet. 2006, 62, 1455.
• 48.Wojciechowski E., Wnęk S., Lewińska Z., Frigin C.: Badania serologiczne w kierunku gorączki Q grupy zwierząt rzeźnych i hodowlanych. Przegl. Epidemiol. 1957, 11, 65.